Tuberculosis - The Aurum Institute

Watch: IMPAACT4TB Project 3HP rollout

We have carried Tuberculosis (TB) for far too long, we need to move away from a narrow focus on treatment in order to end TB. Despite TB being both a curable and treatable disease, millions of people...
PhD Opportunity

The International Division and Implementation Research Division at the Aurum Institute, the TB Centre and Johns Hopkins University, CHAI, Zimbabwe and KNCV Ethiopia are offering a PhD bursary to suppo...
High risk of Tuberculosis in people living with HIV

The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV. The blood mRNA biomarker differentiate...
New study: Optimising the delivery for tuberculosis preventive treatment

The Aurum Institute is implementing a new study to assess the delivery of TB preventive treatment (TPT) in three countries, to generate critical knowledge to improve TPT uptake, implementation and ou...
After setbacks, rollout of new TB prevention pills to start in six districts

This article was originally written by Tiyese Jeranji for Spotlight on 14th April 2021. After various delays and setbacks, new, less toxic, short-course tuberculosis (TB) prevention therapy is fi...
Aurum launches TB Preventative Treatment rollout in Ghana

Aurum Institute Ghana, recently launched the rollout of 3HP, a new, less toxic, short-course tuberculosis (TB) prevention therapy (TPT). This is part of the IMPAACT4TB project, implemented by a cons...
New grant to provide an analysis of programmatic treatment of drug-resistant TB

Aurum Senior Researcher Dr Yuri van der Heijden, has received a 5-year grant for a study on drug-resistant TB from the National Institutes of Health (NIH). Van der Heijden, holds a joint appointmen...
Fundação Aurum partners with Mozambican government to help end TB

Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Aurum at 11th IAS Conference on HIV science

Aurum experts recently presented at the 11th International Aids Society (IAS) Conference, which brought together thousands of HIV professionals virtually from 18 to 21 July. On the opening day of the...
Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
TB Prevention in People With HIV: How Short Can We Go?

...
Call to action for an invigorated drive to scale up TB prevention

...
Strengthening the Mentorship and Leadership Capacity of HIV/AIDS and Tuberculosis Researchers in South Africa

Desai, M.M., Göç, N., Chirwa, T., Manderson, L., Charalambous, S., Curry, L.A. and Linnander, E., 2021. Strengthening the Mentorship and Leadership Capacity of HIV/AIDS and Tuberculosis Researchers ...
Dablapmeds: A convenient shortcut to medication collection

The Aurum Institute continues to bring patient-centred healthcare solutions, this time, supporting the Department of Health Dablapmeds initiative. Dablap is a colloquial term for shortcut and is the n...
The Aurum Institute at the 52nd Union World Conference on Lung Health

Aurum has extensive experience in TB research, specifically TB treatment clinical trials, TB prevention trials with vaccines, preventive therapy, epidemiological studies, implementation research an...
Opt4TPT South Africa study team recruits and enrols participants

On 16 September 2021, the Opt4TPT study team in South Africa implemented by The Aurum Institute, started enrolling patients visiting the Chiawelo Community Health Centre (CHC) for antiretroviral the...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
Concern as TB Preventative Treatment Declines

...
Ascent South Africa launches in Cape Town

The Adherence Support Coalition to End TB (ASCENT) project is collaborating with City Health, and TB HIV Care funded by the Global Fund to implement Digital Adherence Technologies (DATs), to sup...